Organization · Private Equity
JD Capital
JD Capital is a private equity investment management firm based in Beijing, specializing in minority share investments and mergers and acquisitions within mainland China. The firm manages approximately RMB 59.1 billion in total assets across a diverse portfolio of 367 companies.
Overview
What JD Capital does
What JD Capital is
JD Capital is a private equity investment management firm based in Beijing, specializing in minority share investments and mergers and acquisitions within mainland China. The firm manages approximately RMB 59.1 billion in total assets across a diverse portfolio of 367 companies.
How it participates in the startup ecosystem
The current public profile supports funder and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 2007
- Approximate age
- About 19 years
- Structured capabilities
- Funder · Publisher
- Last reviewed
- March 27, 2026
Official channels
Find JD Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
JD Capital as a funder
Investment thesis
JD Capital focuses on equity investment in high-quality enterprises within the consumer, healthcare, and advanced manufacturing sectors in mainland China, employing a minority share investment strategy and exploring merger and acquisition opportunities.
Focus narrative
JD Capital primarily invests in high-quality enterprises within the consumer, healthcare, and advanced manufacturing sectors in mainland China. The organization employs a minority share investment strategy, supplemented by merger and acquisition opportunities, to maximize growth potential.
Value beyond capital
JD Capital adds value to its portfolio companies through a professional investment team, a top-down deal sourcing strategy, and a rigorous risk management model, ensuring that investments are well-positioned for growth and success.
Focus and fit
- Sectors
- ConsumerHealthcare
- Regions
- Asia
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Notable portfolio companies include Autek China, Jiudian Pharmaceutical, Weili Healthcare, Guangxi LiuYao Group, and Nanlu Ophthalmology Hospital, all of which are engaged in the healthcare and pharmaceutical sectors.
Capability profile
JD Capital as a publisher
Editorial focus
JD Capital focuses on equity investment and management, emphasizing responsible investment practices. The organization aims to create long-term value for shareholders while minimizing risks, and is committed to ESG investment practices as a signatory to the United Nations Principles for Responsible Investment.
Audience value
JD Capital aims to create long-term value for its shareholders through responsible investment practices across various sectors, including consumer goods, healthcare, and advanced manufacturing.
Format and cadence
- Content formats
- blog
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Investors
Flagship work and coverage
Flagship properties
JD Capital produces several content properties, including JD News, a news platform providing updates and insights, and JD Insights, which features articles on investment trends and market analysis.
Common questions
What to know about JD Capital
Upseed classifies JD Capital under the Private Equity organization type. Its current public profile includes funder and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.